Is INO or IRD more undervalued in 2026?

CirclFi compares Inovio Pharmaceuticals, Inc. (INO) and Opus Genetics, Inc. (IRD) using 13 institutional-grade valuation models. INO has a Quality of Company score of 4.3/10 while IRD scores 5.2/10.

Which is a better buy — INO or IRD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INO and IRD valuations compare?

INO at $1.31 and IRD at $4.36 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INO vs IRD Valuation Comparison 2026 — Intrinsic Value Analysis

INO

Pharmaceutical Preparations

Inovio Pharmaceuticals, Inc.

Quality

4.3

out of 10

Value Trap

WARN

Price

$1.31

Last close

Models

8/13

Active

IRD

Pharmaceutical Preparations

Opus Genetics, Inc.

Quality

5.2

out of 10

Value Trap

WARN

Price

$4.36

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	INO Fair Value	INO Upside	IRD Fair Value	IRD Upside
Bayesian DCF	Intrinsic	$0.46	-65.0%	$1.14	-74.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.08	+58.8%	$0.10	-98.0%
PWERM	Option-Based	$1.58	+20.5%	$4.95	+13.6%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INO vs IRD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INO vs IRD — Which Stock Is More Undervalued?

IRD scores higher with a 5.2/10 quality rating vs INO's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inovio Pharmaceuticals, Inc. (INO) and Opus Genetics, Inc. (IRD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INO currently trades at $1.31 with a QOC of 4.3/10, while IRD trades at $4.36 with a QOC of 5.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).